These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9587036)

  • 121. Homocysteine, oxidative stress, and vascular disease.
    Welch GN; Upchurch GR; Loscalzo J
    Hosp Pract (1995); 1997 Jun; 32(6):81-2, 85, 88-92. PubMed ID: 9194803
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Role of endothelium in thrombosis and hemostasis.
    Wu KK; Thiagarajan P
    Annu Rev Med; 1996; 47():315-31. PubMed ID: 8712785
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Homocysteine and glutathione peroxidase-1.
    Lubos E; Loscalzo J; Handy DE
    Antioxid Redox Signal; 2007 Nov; 9(11):1923-40. PubMed ID: 17822368
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia.
    Blom HJ
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S131-4. PubMed ID: 9587041
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.
    van Guldener C; Stehouwer CD
    Semin Thromb Hemost; 2000; 26(3):281-9. PubMed ID: 11011845
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
    Hansrani M; Stansby G
    Cochrane Database Syst Rev; 2002; (3):CD003285. PubMed ID: 12137685
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
    Sainani GS; Sainani R
    J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Hyperhomocysteinaemia and atherothrombosis.
    Cattaneo M
    Ann Med; 2000 Dec; 32 Suppl 1():46-52. PubMed ID: 11209982
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Homocysteine and vascular dysfunction.
    Lentz SR
    Life Sci; 1997; 61(13):1205-15. PubMed ID: 9324062
    [TBL] [Abstract][Full Text] [Related]  

  • 131. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 133. [The main determinants of endothelial dysfunction].
    Garaliene V
    Medicina (Kaunas); 2006; 42(5):362-9. PubMed ID: 16778463
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Hyperhomocysteinaemia and vascular disease.
    Townend J; O'Sullivan J; Wilde JT
    Blood Rev; 1998 Mar; 12(1):23-34. PubMed ID: 9597195
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Homocysteine and vascular disease.
    Hankey GJ; Eikelboom JW
    Lancet; 1999 Jul; 354(9176):407-13. PubMed ID: 10437885
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Systemic nature of endothelial dysfunction in atherosclerosis.
    Anderson TJ; Gerhard MD; Meredith IT; Charbonneau F; Delagrange D; Creager MA; Selwyn AP; Ganz P
    Am J Cardiol; 1995 Feb; 75(6):71B-74B. PubMed ID: 7863979
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Endothelium-derived factors and peripheral vascular disease.
    Cooke JP
    Cardiovasc Clin; 1992; 22(3):3-17. PubMed ID: 1600550
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Can lowering homocysteine levels reduce the incidence of stroke?
    Sarkar PK; Lambert L
    J Clin Pharm Ther; 1999 Oct; 24(5):331-8. PubMed ID: 10583695
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Markers of platelet activation and oxidant stress in atherothrombotic disease.
    FitzGerald GA; Tigges J; Barry P; Lawson JA
    Thromb Haemost; 1997 Jul; 78(1):280-4. PubMed ID: 9198167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.